DOJ Reschedules Medical Cannabis to Schedule III, Splitting the Industry in Two
The U.S. Department of Justice and the DEA issued a final order on April 23, 2026, moving FDA-approved cannabis drug products and state-licensed medical cannabis to Schedule III of the Controlled